What we’re seeing in the data, the policy environment, and the field.
Analysis written when the data has something worth saying. We publish based on substance rather than volume, for pharmaceutical commercial teams, policy audiences, and the public interest community.
Featured Article
ASCO 2026: New Data Highlight Advances in Prostate Cancer Treatments
New research presented at the 2026 ASCO Annual Meeting, held May 29 through June 2 in Chicago, showed that Nubeqa (darolutamide) was […]
Research Library
Long-form analysis built on the full census of Medicare claims.
Methodology included, so your team can check the work.
No posts found.
Latest Articles
No posts found.